Analysis of altered protein expression patterns of Chlamydia pneumoniae by an integrated proteome-works system

Journal of Proteome Research

Volumn 3, Issue 4, 2004, Pages 878-883

  Mukhopadhyay, Sanghamitra ^a   Miller, Richard D ^a   Summersgill, James T ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

2 D gel analysis; Chlamydia pneumoniae; PDQuest software; Protein expression; Proteomics

Indexed keywords

ADENYLATE KINASE; ANTIOXIDANT; BACTERIAL PROTEIN; CYSTEINE; GAMMA INTERFERON; METHIONYL AMINOPEPTIDASE; PROTEOME; THIOL;

ARTICLE; BACTERIAL GROWTH; CELL DIVISION; CHLAMYDOPHILA PNEUMONIAE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RELIABILITY;

BACTERIAL PROTEINS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; INTERFERON TYPE II; PROTEOME; PROTEOMICS;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE;

EID: 4444342918     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0400031     Document Type: Article

References (35)

1. Ramirez, J. A.; Ahkee, S.; Summersgill, J. T.; Ganzel, B. L.; Ogden, L. L.; Quinn, T. C.; Gaydos, C. A.; Bobo, L. L.; Hammerschlag, M. R.; Robin, P. M.; LeBar, W.; Grayston, J. T.; Kuo, C.-C.; Campbell, L. A.; Patton, D. L.; Dean, D.; Schachter, J. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 1996, 125, 979-982.
2. Campbell, L. A.; Kuo, C.-C.; Grayston, J. T. Chlamydia pneumoniae and cardiovascular disease. Emerg. Infect. Dis. 1998, 4, 571-579.
3. Kuo, C.-C.; Shor, A.; Campbell, L. A.; Fukushi, H.; Patton, D. L.; Gryaston, J. T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 1993, 167, 841-849.
4. Maass, M.; Bartels, C.; Engel, P. M.; Mamat, U.; Sievers, H. H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 1998, 31, 827-832.
5. Grayston, J. T.; Kuo, C.-C.; Coulson, A. S.; Campbell, L. A.; Lawrence, R. D.; Ming-Jong, L. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995, 93, 3397-3400.
6. Kuo, C.-C.; Gown, A. M.; Benditt, E. P.; Grayston, J. T. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Artheroscler. Thromb. 1992, 13, 1501-1504.
7. Kutlin, A.; Roblin, P. M.; Hammerschlag, M. R. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob. Agents Chemother. 1999, 43, 2268-2272.
8. Gaydos, C. A.; Summersgill, J. T.; Sahney, J. A.; Ramirez, J. A.; Quinn, T. C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 1996, 64, 1614-1620.
9. Godzik, K.; O'Brien, E. R.; Wang, S. W.; Kuo, C.-C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 1995, 168, 1231-1235.
10. Molestina, R. E.; Dean, D.; Ramirez, J. A.; Summersgill, J. T. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect. Immun. 1998, 66, 1360-1376.
11. Mehta, S. J.; Miller, R. D.; Ramirez, J. A.; Summersgill, J. T. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ role of tryptophan catabolism. J. Infect. Dis. 1998, 177, 1326-1331.
12. Pantoja, L. G.; Miller, R. D.; Ramirez, J. A.; Molestine, R. E.; Summersgill, J. T. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect. Immun. 2001, 69, 7927-7932.
13. Hogan, R. J.; Mathews, S. A.; Mukhopadhyay, S.; Summersgill, J. T.; Timms, P. T. Chlamydial persistence: Beyond the biphasic paradigm. Infect. Immun. 2004, in press.
14. Byrne, G. I.; Ouellette, S. P.; Wang, Z.; Rao, J. P.; Lu, L.; Beatty, W. L.; Hudson, A. P. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokines during persistent infection of HEp2 cells. Infect. Immun. 2001, 69, 5423-5429.
15. Mathews, S. A.; George, C.; Flegg, C.; Stenzel, D.; Timms, P. Differential expression of ompA, ompB, pyk, nlpD, and Cpn0585 genes between normal and interferon-γ treated cultures of Chlamydia pneumoniae. Microb. Pathog. 2001, 30, 337-345.
16. Hogan, R. J.; Mathews, S. A.; Kutlin, A.; Hammerschlag, M. R.; Timms, P. Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microbial Pathogenesis. 2003, 34, 11-16.
17. Molestina, R. E.; Klein, J. B.; Miller, R. D.; Pierce, W. H.; Ramirez, J. A.; Summersgill, J. T. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect. Immun. 2002, 70, 2976-2981.
18. Noda, L. In The Enzyme; Boyer, P. D., Ed.; Academic Press: New York, Vol. 8; 1973 pp 279-305.
19. Atkinson, D. E. In Cellular Energy Metabolism and its Regulation; Atkinson, D. E. Ed.; Academic Press: Orlando FL, pp 85-107.
20. Munier-Lehmann, H.; Chenal-Francisque V.; Ionescu M. Christova, P.; Foulon, J.; Carnieal, E.; Barzu, O. Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent. Biochem. J. 2003, 373, 515-522.
21. Markaryan, A.; Zaborina, O.; Punj, V.; Chakrabarty, A. Adenylate kinase as a virulence factor of Pseudomonas aeruginosa. J. Bacteriol. 2001, 183, 3345-3352.
22. Jones, A. L.; Beveridge, T. J.; Woods, D. E. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 1996, 64, 782-790.
23. Loprasert, S.; Sallabhan, R.; Whangsuk, W.; Mongkolsuk, S. Compensatory increase in ahpC gene expression and its role in protecting Burkholderia pseudomallei against reactive nitrogen intermediates. Arch. Microbiol. 2003, 180, 498-502.
24. Sherman, D. R.; Mdluli, K.; Hickey, M. J.; Arain, T. M.; Morris, S. L.; Barry, C. E. 3rd; Stover, C. K. Compensatory ahpC gene expression in isoniazid-resistant. Mycobacterium tuberculosis. Science. 1996. 272, 1641-1643.
25. Igietseme, J. U.; Ananaba, G. A.; Candal, D. H.; Lyn, D.; Black, C. M. Immune control of chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction, typtophan catabolism and iron deprivation. Microbiol. Immunol. 1998. 42, 617-625.
26. Rottenberg, M. E.; Gigliotti-Rothfuchs, A. C.; Gigliotti, D.; Svanholm, C.; Bandholtz, L.; Wigzell, H. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J. Immunol. 1999, 162, 2829-2836.
27. Ramsey, K. H.; Miranpuri, G. S.; Sigar, M.; Ouellette, S.; Byrne, G. I. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect. Immun. 2001, 69, 5131-5137.
28. Bryk, R.; Griffin, P.; Nathan, C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 2000, 407, 211-215.
29. Graham, A.; Hogg, N.; Kalyanaraman, B.; O'Leary, V.; Darley-Usmar, V.; Moncada, S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 1993. 330, 181-185.
30. Hackstadt, T. In Chlamydia: Intracellular Biology, Pathogenesis, and Immunity, Stephens, R. S., Ed.; American Society of Microbiologists: Washington, DC, 1999, pp 101-138.
31. Klein, M.; Kotz, A.; Bernardo, K.; Kornke, M. Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein. J. Clin. Microbiol. 2003, 41, 1957-1962.
32. + T cell response. J. Immunol. 2003, 171, 4742-4749.
33. Kuo, C.-C.; Jackson, L. A.; Campbell, L. A.; Grayston, J. T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 1995, 8, 451-461.
34. Hammerschlag, M. R.; Chirgwin, K.; Roblin, P. M.; Gelling, M.; Dumornay, W.; Mandel, L.; Smith, P.; Schachter, J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 1992, 14, 178-182.
35. Vandahl, B. B.; Birkeland, S.; Demol, H.; Hoorelbeke, B.; Christiansen, G.; Vandekerckohove, J.; Gevaert, K. Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis 2001, 22, 1204-1223.